Stanford Cancer Institute
In research, Stanford Cancer Institute stands highest in Medicine (#6,351 of 17,978 worldwide) and Health Sciences (#8,488 of 20,462 worldwide), over all time.
- World rank, 2022–2025
- #16,038 of 28,054 · #15,584 all time
- Rank in ??
- #309 of 692
- Research works
- 322 ▲ 49% vs 2013–17
- Citations
- 9.1k 28.2 per fractional work
- Top-10% rate
- 20.4% record average 16.5%
- Open access
- 43% world 28%
What is Stanford Cancer Institute known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #6,351 of 17,978 | 20.6% | 227 | |
| Health SciencesDomain | #8,488 of 20,462 | 20.6% | 232 |
Each strip is that field’s whole ranked pool, with the notch where Stanford Cancer Institute sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.0×. Every wedge is a field page.
- Immunology and Microbiology 4.0×
- Medicine 3.6×
- Biochemistry, Genetics and Molecular Biology 3.2×
- Economics, Econometrics and Finance 0.8×
- Physics and Astronomy 0.5×
- Health Professions 0.5×
- Social Sciences 0.2×
- Mathematics 0.1×
- Engineering 0.1×
- Neuroscience 0.1×
- Agricultural and Biological Sciences 0.1×
- Chemistry 0.1×
- Computer Science 0.0×
- Materials Science 0.0×
- Psychology 0.0×
- Arts and Humanities 0.0×
Which keywords describe research at Stanford Cancer Institute?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Immunotherapy, Prognostic Factors, Lymphoma, Cancer Immunotherapy, Targeted Therapy, Tumor Regression and Radiotherapy.
- Tumor Staging
- Molecular Profiling
- Survival
- EGFR Mutations
- Precision Medicine
- Genomic Profiling
- Mutational Signatures
- Adjuvant Therapy
- Neoadjuvant Therapy
- Genomic Instability
- PD-1 and PD-L1
- Survival Analysis
- Breast Cancer
- Clinical Practice Guidelines
- Cancer
- Chimeric Antigen Receptor
- Tumor Regression
- Targeted Therapy
- Lymphoma
- Immunotherapy
- Chemotherapy
- Prognostic Factors
- Cancer Immunotherapy
- Radiotherapy
- CAR T Cells
- Leukemia
- Clinical Trials
- Tumor Microenvironment
- Quality of Life
- Immune Checkpoint Blockade
- Hematopoietic Stem Cells
- Health-related Quality of Life
- Cell-Free DNA
- Cancer Genomics
- Rituximab
- PET Imaging
- ALK Inhibitors
- Molecular Subtypes
- Treatment Guidelines
- Cetuximab
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy9▲ 19×21 topics
- Immunotherapy8▲ 18×15 topics
- Prognostic Factors6▲ 21×13 topics
- Lymphoma6▲ 54×3 topics
- Cancer Immunotherapy5▲ 53×3 topics
- Targeted Therapy5▲ 36×5 topics
- Radiotherapy5▲ 20×11 topics
- Tumor Regression5▲ 70×2 topics
- CAR T Cells4▲ 91×1 topic
- Chimeric Antigen Receptor4▲ 91×1 topic
- Leukemia4▲ 80×2 topics
- Cancer4▲ 4.7×25 topics
- Clinical Trials4▲ 8.0×6 topics
- Clinical Practice Guidelines4▲ 9.8×8 topics
- Tumor Microenvironment4▲ 12×7 topics
- Breast Cancer3▲ 21×9 topics
- Quality of Life3▲ 2.9×11 topics
- Survival Analysis3▲ 15×7 topics
- Immune Checkpoint Blockade3▲ 35×1 topic
- PD-1 and PD-L13▲ 35×1 topic
- Hematopoietic Stem Cells2▲ 43×3 topics
- Genomic Instability2▲ 31×3 topics
- Health-related Quality of Life2▲ 14×3 topics
- Neoadjuvant Therapy2▲ 14×5 topics
- Cell-Free DNA2▲ 33×2 topics
- Adjuvant Therapy2▲ 23×2 topics
- Cancer Genomics2▲ 42×1 topic
- Mutational Signatures2▲ 42×1 topic
- Rituximab2▲ 20×2 topics
- Genomic Profiling2▲ 28×2 topics
- PET Imaging2▲ 17×4 topics
- Precision Medicine2▲ 6.1×5 topics
- ALK Inhibitors2▲ 44×1 topic
- EGFR Mutations2▲ 44×1 topic
- Molecular Subtypes2▲ 33×3 topics
- Survival2▲ 20×4 topics
- Treatment Guidelines2▲ 13×2 topics
- Molecular Profiling2▲ 25×3 topics
- Cetuximab2▲ 29×2 topics
- Tumor Staging2▲ 22×2 topics
Which research topics does Stanford Cancer Institute publish most on?
By volume in 2022–2025: CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics and Lung Cancer Treatments and Mutations.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy research Oncology 4 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 3 works
- 3 Cancer Genomics and Diagnostics Cancer Research 2 works
- 4 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
- 5 Acute Myeloid Leukemia Research Hematology 2 works
- 6 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 1 works
- 7 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 1 works
- 8 Childhood Cancer Survivors' Quality of Life Pediatrics, Perinatology and Child Health 1 works
- 9 Cancer survivorship and care Oncology 1 works
- 10 Cancer Treatment and Pharmacology Oncology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Stanford Cancer Institute's research output changed?
Output in 2018–2022 was 49% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Palo Alto
- Toyota Research Institute
- VMware (United States)
- Arc Research Institute
- Institute for Stem Cell Biology and Regenerative Medicine
- Emerson Collective (United States)
- Peninsula Open Space Trust
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.